- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Recombinant Bcl-2 antibody is a specialized reagent for detecting the anti apoptotic protein Bcl-2, which regulates mitochondrial outer membrane stability. By preventing the release of pro apoptotic factors, Bcl-2 safeguards cells from programmed cell death. Its activity is central to development, immune regulation, and tumor progression. Because of its role in blocking apoptosis, Bcl-2 is a target of intensive investigation in cancer biology and therapeutic development.
Bcl-2 belongs to a family of proteins that balance pro survival and pro death signals. It binds to BH3 domain containing partners such as Bax to prevent mitochondrial pore formation. This activity preserves mitochondrial potential and prevents activation of the caspase cascade. Dysregulation of Bcl-2 expression allows abnormal cells to survive, which is particularly evident in lymphomas and other malignancies where Bcl-2 overexpression is common.
The Recombinant Bcl-2 antibody clone BCL2/2210R provides accurate and reproducible recognition of this protein. Clone BCL2/2210R benefits from recombinant production, which eliminates variability and ensures stable quality across experiments. It has been used in oncology to study how Bcl-2 expression contributes to therapy resistance, in immunology to assess lymphocyte survival, and in neuroscience to explore protective mechanisms in neurons under stress. Its reproducibility makes it well suited for detailed mechanistic studies.
As a clinical biomarker, Bcl-2 detection provides diagnostic and prognostic information in a range of cancers. Clone BCL2/2210R has contributed to studies showing how altered Bcl-2 levels correlate with tumor aggressiveness and patient outcomes. In addition, this antibody aids research into novel therapies such as BH3 mimetics, which are designed to neutralize Bcl-2 and restore apoptotic signaling in malignant cells.
NSJ Bioreagents provides this Recombinant Bcl-2 antibody to advance research in apoptosis regulation and cancer treatment. Researchers may also encounter this protein under alternate terms such as apoptosis regulator Bcl-2 antibody, BCL2 proto oncogene antibody, B cell lymphoma 2 protein antibody, and mitochondrial outer membrane survival protein antibody. These alternate names highlight the broad relevance of Bcl-2 across biological disciplines.
The optimal dilution of the recombinant Bcl-2 antibody for each application should be determined by the researcher.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.
Recombinant full length human protein was used as the immunogen for this recombinant Bcl-2 antibody.
Store the recombinant Bcl-2 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.